Results 141 to 150 of about 12,244 (197)

Three Decades of Hantavirus Management in Chile: Lessons for Europe. [PDF]

Lancet Reg Health Eur
Le Corre N, Martínez-Valdebenito C, Henriquez C, Angulo J, Acuña M, Vial C, Vial PA, Mertz G, Ferrés M.   +8 more
europepmc   +1 more source

Enfermedades infecciosas en Colombia

Archivos de Medicina (Manizales), 2006
openaire   +2 more sources

Structured integration of rapid antimicrobial susceptibility testing and antimicrobial resistance detection into an antimicrobial stewardship programme for bacteraemia. [PDF]

JAC Antimicrob Resist
Halperin AV, Gómez-León S, Escudero-Sánchez R, Corbacho-Loarte MD, Suárez-Carantoña C, Saez de la Fuente J, Retamar-Gentil P, Cantón R.   +7 more
europepmc   +1 more source

[Twenty-five myths in infectious diseases in primary care associated with overdiagnosis and overtreatment]. [PDF]

Aten Primaria, 2018
Llor C, Moragas A, Cordoba G.
europepmc   +1 more source

Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. [PDF]

Nat Commun
Català-Moll F, Blázquez-Bondia C, Farré-Badia J, Torres F, Manzardo C, Bonfill E, Curran A, Domingo P, Podzamczer D, Force L, Falcó V, Parera M, Casadellà M, Miró JM, Noguera-Julian M, Paredes R, ADVANZ-4 MISTRAL investigators.   +16 more
europepmc   +1 more source

A matched case-control study on Escherichia coli factors contributing to sepsis and septic shock in bacteraemic patients. [PDF]

Commun Med (Lond)
Maldonado N, López-Hernández I, Valik JK, López-Cortes LE, Martínez Pérez-Crespo PM, García-Montaner A, Alcalde-Rico M, Sousa-Domínguez A, Jover Sáenz A, Goikoetxea J, Pulido-Navazo Á, Buzón-Martín L, Aller AI, Boix-Palop L, Del Arco-Jiménez A, Smithson-Amat A, Sánchez Calvo JM, Natera-Kindelán C, Reguera Iglesias JM, Armiñanzas-Castillo C, Galán-Sánchez F, Bahamonde A, Gea-Lázaro I, Castelló-Abietar C, Pérez-Camacho I, Marrodán-Ciordia T, Becerril-Carral B, Naucler P, Pascual-Hernández Á, Rodríguez-Baño J, PROBAC REIPI/GEIRAS-SEIMC/SAMICEI Group.   +30 more
europepmc   +1 more source

Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024). [PDF]

Open Forum Infect Dis
Ryan P, Berenguer J, Ramos-Ruperto L, Vera M, Martín-Carbonero L, Pérez-Latorre L, De Los Santos I, Pinto A, Vivancos MJ, Orviz E, Álvarez B, Sanz J, Ruiz-Seco P, Torres R, Brazal B, De Miguel M, López-Centeno B, Jarrín I, Resino S, Bellón JM, González-García J.   +20 more
europepmc   +1 more source

[Coexistence of primary central nervous system lymphoma and cerebral toxoplasmosis in a patient with advanced HIV infection and negative serology]. [PDF]

Rev Esp Quimioter
Velasco-Montes J, Lista-Araujo MT, de-Fuentes-Corripio I, Barreras-García A.   +3 more
europepmc   +1 more source

How to use novel antimicrobials beyond official indications: an expert consensus. [PDF]

JAC Antimicrob Resist
Retamar-Gentil P, Alegre-Albendea M, Valiente De Santis L, Castón-Osorio JJ, Márquez-Gómez I, Corzo-Delgado JE, Praena-Segovia J, Herrero-Rodríguez C, Esteban-Moreno MÁ, Martín-Aspas A, Jiménez-Aguilar P, Martínez-Marcos FJ, López-Cárdenas S, Ojeda-Burgos G, Sadyrbaeva-Dolgova S, Anguita-Santos F, Rodríguez Baño J, Palacios-Baena ZR.   +17 more
europepmc   +1 more source